checkAd

     217  0 Kommentare Telix Files Registration Statement for Proposed Initial Public Offering in the United States

    MELBOURNE, Australia, May 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has filed a registration statement on Form F-1 (Registration Statement) with the United States (U.S.) Securities and Exchange Commission (SEC) today (U.S. time) relating to a proposed initial public offering (Offering) of its American Depository Shares (ADSs), representing the Company’s ordinary shares, in the U.S. Telix has applied to list the ADSs on the Nasdaq Global Market under the symbol “TLX”.

    The number of ordinary shares to be represented by each ADS, the number of ADSs to be offered and the price per ADS for the proposed Offering have not yet been determined. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed.

    Jefferies, Morgan Stanley, Truist Securities and William Blair will act as joint book-running managers for the proposed Offering.

    The proposed Offering will be made only by means of a prospectus under the U.S. Securities Act of 1933. Copies of the preliminary prospectus, when available, may be obtained from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by phone at (877) 821-7388, or by email at prospectus_department@jefferies.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by email at prospectus@morganstanley.com; Truist Securities, Inc., Attention: Prospectus Department, 3333 Peachtree Road NE, 9th floor, Atlanta, GA 30326, by telephone at (800) 685-4786, or by email at TruistSecurities.prospectus@Truist.com; or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606; by phone at (800) 621-0687; or by e-mail at prospectus@williamblair.com. Australian investors are only eligible to invest under the prospectus if they are exempt from disclosure (for example, as sophisticated or professional investors) under the Corporations Act 2001 (Cth).

    A Registration Statement relating to the securities referred to herein has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the Registration Statement becomes effective. This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte

    Aktuelle Themen


    globenewswire
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Verfasst von globenewswire
    Telix Files Registration Statement for Proposed Initial Public Offering in the United States MELBOURNE, Australia, May 17, 2024 (GLOBE NEWSWIRE) - Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has filed a registration statement on Form F-1 (Registration Statement) with the United States (U.S.) …